Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply

Transfusion

Volumn 40, Issue 11, 2000, Pages 1399-1406

  De Fernando Oliveira, C ^a,b,c,d,e,f   Diaz, Ricardo S ^a,b,c,d,e,f   Machado, Daisy M ^a,b,c,d,e,f   Sullivan, Marian T ^a,b,c,d,e,f   Finlayson, Teresa ^a,b,c,d,e,f   Gwinn, Marta ^a,b,c,d,e,f   Lackritz, Eve M ^a,b,c,d,e,f   Williams, Alan E ^a,b,c,d,e,f   Kessler, Debra ^a,b,c,d,e,f   Operskalski, Eva A ^a,b,c,d,e,f   Mosley, James W ^a,b,c,d,e,f   Busch, Michael P ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOLLAND LABORATORY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NEW YORK BLOOD CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DNA SEQUENCE; FEMALE; HEMOPHILIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MALE; SCREENING TEST; SEQUENCE ANALYSIS; SEROTYPE; UNITED STATES; VIRUS DETECTION; VIRUS STRAIN;

BLOOD DONORS; HIV-1; HUMANS; POPULATION SURVEILLANCE; UNITED STATES; VARIATION (GENETICS);

EID: 0033681157     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40111399.x     Document Type: Article

References (59)

1. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O
2. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K
3. Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology
4. Genetic subtypes of HIV-1
5. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1
6. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: Generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO network for HIV isolation and characterization
7. The molecular epidemiology of HIV in Asia
8. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: Identification of a new envelope subtype
9. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil
10. HIV-1 subtypes and male-to-female transmission in Thailand
11. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand
12. Multiple introductions of HIV-1 subtype E into the Western hemisphere
13. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes
14. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin
15. Genetic characterization of HIV-1 strains in the Baltic countries and Russia
16. Distribution of HIV-1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil
17. Most HIV-1 genetic subtypes have entered Sweden
18. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion
19. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors
20. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment
21. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993
22. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa
23. HIV-1 sequence subtype D in the United States
24. Detection of diverse HIV-1 genetic subtypes in the USA
25. Surveillance for human immunodeficiency virus type 1 group O infections in the United States
26. HIV-1 group O virus identified for the first time in the United States
27. Presence of human immunodeficiency virus (H1V) type 1 subtype A infection in a New York community with high HIV prevalence: A sentinel site for monitoring HIV genetic diversity in North America. Centers for Disease Control and Prevention-Bronx Lebanon HIV Serosurvey Team
28. Surveillance for variant strains of HIV: Subtype G and group O HIV-1
29. Efficacies of US Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2
30. Sensitivity of United States HIV antibody tests for detection of HIV- 1 group O infections
31. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions
32. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository
33. Human immunodeficiency virus type 1-infected blood donors: Epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group
34. Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: An analysis of tat and C2-V3 env regions
35. Rapid molecular epidemiology of human immunodeficiency virus transmission
36. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission
37. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay
38. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes
39. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation
40. Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA
41. Divergence of H1V-1 quasi-species in an epidemiologic cluster
42. Global burden of the HIV pandemic
43. Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences
44. Two subtypes of HIV-1 among injection-drug users in southern China
45. Introduction of HIV-1 subtypes C, E and A into Austria
46. Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania
47. Detection of large numbers of HIV-1 group M non-B subtypes in New York City
48. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France
49. Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies
50. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda
51. Genetic diversity and HIV detection by polymerase chain reaction
52. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma
53. Subtype-specific problems with quantification of plasma HIV-1 RNA
54. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes
55. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma
56. Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization
57. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing
58. HIV type 1 V3 serotyping of Tanzanian samples: Probable reasons for mismatching with genetic subtyping